alexa Targeted Suppression of a Dystrophin Pseudo-exon using Antisense Oligonucleotides
ISSN: 2157-7412

Journal of Genetic Syndromes & Gene Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Targeted Suppression of a Dystrophin Pseudo-exon using Antisense Oligonucleotides

Barrett LW1,2, Fletcher S1,2, Barreo RA1, Bellgard MI1, Flanigan KM1, Wong B1 and Wilton SD1,2*

1Western Australian Neuroscience Research Institute, Australia

2Centre for Comparative Genomics, Murdoch University, Australia

*Corresponding Author:
Steve Wilton
Foundation Chair in Molecular Therapies
Murdoch University, Australia
Tel: +61 417 982 365
E-mail: [email protected]

Received date: June 30, 2014; Accepted date:July 28, 2014; Published date: July 30, 2014

Citation: Barrett LW, Fletcher S, Barreo RA, Bellgard MI, Flanigan KM, et al. (2014) Targeted Suppression of a Dystrophin Pseudo-exon using Antisense Oligonucleotides. J Genet Syndr Gene Ther 5:235. doi:10.4172/2157-7412.1000235

Copyright: © 2014 Barrett LW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Antisense oligonucleotide induced exon skipping is showing great promise as a potential therapy to restore functional dystrophin expression in Duchenne muscular dystrophy. Redirecting mRNA processing can excise one or more exons flanking frame-shifting deletions or duplications so that the reading frame is restored and a Becker muscular dystrophy-like transcript is induced. Here, we report the application of exon skipping to excise a diseasecausing 72 bp pseudo-exon from the mature dystrophin mRNA. This pseudo-exon arises from a single T>G base change in intron 47 that creates an acceptor site with a strong consensus splice site score. Although in-frame, this pseudo-exon contains several stop codons and its inclusion is consistent with a diagnosis of Duchenne muscular dystrophy. The 21 year old patient is no longer ambulant but can stand and sit unassisted, indicating leaky premRNA processing and the generation of some normal transcripts has delayed the muscle wasting to some extent. In cases where the DMD lesion activates one or more cryptic splice sites and results in the retention of intronic sequences in that mature mRNA, exon skipping has the potential to generate a normal gene transcript. Antisense oligonucleotides targeted to the mutant splice site were able to remove the pseudo-exon from the mature transcript and restore full-length dystrophin expression. This is in contrast to most exon-skipping strategies for Duchenne muscular dystrophy in which antisense oligonucleotides are used to restore expression but the induced Becker muscular dystrophy-like transcript is shorter and potentially less functional than the full-length mRNA. As such, pseudo-exons may be particularly amenable to exon skipping, especially when basal levels of expression have raised endogenous dystrophin levels, reducing disease severity and should mitigate immune responses to the induced normal isoform.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords